TMCnet - World's Largest Communications and Technology Community



Research and Markets: Global Malignant Glioma Clinical Trials Review 2014
[April 15, 2014]

Research and Markets: Global Malignant Glioma Clinical Trials Review 2014

DUBLIN --(Business Wire)--

Research and Markets ( has announced the addition of the "Malignant Glioma Global Clinical Trials Review, H1, 2014" report to their offering.

"Malignant Glioma Global Clinical Trials Review, H1, 2014" provides data on the Malignant Glioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malignant Glioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of th sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Malignant Glioma.


  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Top Companies/Organisations Participating in Malignant Glioma Therapeutics Clinical Trials

  • Merck & Co., Inc.
  • Insys Therapeutics, Inc.
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Sanofi
  • Tactical Therapeutics, Inc
  • GlaxoSmithKline plc
  • Celgene Corporation
  • Amgen Inc.
  • Advantagene, Inc.
  • National Cancer Institute
  • Duke University
  • Memorial Sloan Kettering Cancer Center
  • North American Brain Tumor Consortium
  • The University of Texas M. D. Anderson Cancer Center
  • UCLA's Jonsson Comprehensive Cancer Center
  • Northwestern University
  • NCIC Clinical Trials Group
  • European Organization for Research and Treatment of Cancer

For more information visit

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy